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Potassium channels regulate many neuronal functions, including neuronal excitability and
synaptic plasticity, contributing, by these means, to mnemonic processes. In particular, A-
type Kþ currents (IA) play a key role in hippocampal synaptic plasticity. Therefore, we
evaluated the effect of the peptidic toxin Tx3-1, a selective blocker of IA currents, extracted
from the venom of the spider Phoneutria nigriventer, on memory of mice. Administration of
Tx3-1 (i.c.v., 300 pmol/site) enhanced both short- and long-term memory consolidation of
mice tested in the novel object recognition task. In comparison, 4-aminopyridine (4-AP;
i.c.v., 30–300 pmol/site), a non-selective Kþ channel blocker did not alter long-term
memory and caused toxic side effects such as circling, freezing and tonic–clonic sei-
zures. Moreover, Tx3-1 (i.c.v., 10–100 pmol/site) restored memory of Ab25-35-injected mice,
and exhibited a higher potency to improve memory of Ab25-35-injected mice when
compared to control group. These results show the effect of the selective blocker of IA
currents Tx3-1 in both short- and long-term memory retention and in memory impair-
ment caused by Ab25-35, reinforcing the role of IA in physiological and pathological memory
processes.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Voltage-gated Kþ channels (Kv) play a key role in many
neural functions, including control of generation, frequency
and temporal pattern of action potentials (AP) ﬁring (Hille,édio 18, sala 2206,
þ55 55 3220 8978.
Rubin).
. All rights reserved.2001; Migliore and Shepherd, 2002). Mammalian Kv
comprises four primary subfamilies of genes (Kv1, Kv2, Kv3,
Kv4) (Coetzee et al., 1999), and permeates both delayed
rectiﬁer Kþ currents (IK) and transient outward Kþ currents
(IA), the two main voltage-gated Kþ currents. In CA1 pyra-
midal neurons IA currents, encoded by Kv1.4, Kv4.2 or Kv4.3
channels, mediate the amplitude of action potential back-
propagation (Hoffman et al., 1997) and set the threshold for
long term potentiation (LTP) induction (Chen et al., 2006).
An involvement of IA currents in Alzheimer’s disease (AD)
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Ab peptide, a hallmark of AD pathology, modulates these
currents (Plant et al., 2006, Kerrigan et al., 2008), and the
expression of Kv4.2 and Kv4.3 is found increased in the
cortex and hippocampus of Ab-treated rats (Pan et al.,
2004). Given the importance of IA currents for synaptic
plasticity (Chen et al., 2006; Kim and Hoffman, 2008),
modulation of these currents might affect learning and
memory processes.
When studying ionic channels, scientists often turn to
nature’s toolbox, in search of toxins and peptides with high
speciﬁcity and afﬁnity for a given channel. The venom of
the Brazilianwandering spider Phoneutria nigriventer is rich
in toxins that affect ionic channels and neurotransmitter
release. The puriﬁed fraction 3 of Phoneutria venom
(PhTx3) contains 6 toxin isoforms (Tx3-1 to -6) targeting
mainly voltage-dependent calcium channels and potas-
sium currents (Cordeiro et al., 1993; Gomez et al., 2002). In
particular, it has been shown that the toxin Tx3-1 has
inhibitory properties over IA, without affecting any other Kþ
currents (Kushmerick et al., 1999).
The present study investigated the effect of the Pho-
neutria nigriventer toxin Tx3-1 on memory of naïve mice,
and compared with the other potassium channel blocker,
4-aminopyridine (4-AP). Moreover, we tested whether
intracerebroventricular (i.c.v.) injection of Tx3-1 rescue
memory of Ab25-35 injected mice, a recognized model of
AD’s cognitive impairment.
2. Materials and methods
2.1. Animals
Male Swiss mice (3 month old) were used. They were
housed in plastic cages, with free access to water and food
(Guabi, Santa Maria, Rio Grande do Sul, Brazil), and were
maintained on a 12 h/12 h light–dark cycle (lights on from
7:00 to 19:00). Behavioral experiments were conducted in a
sound-attenuated and air-regulated room, where the ani-
mals were habituated 1 h prior to experiments. All animal
experimentation reported in this study was performed
under established standards of the Brazilian law No.11.794/
2008 in accordance with the Policies on the Use of Animals
and Humans in Neuroscience Research, revised and
approved by the Society for Neuroscience Research.
2.2. Drugs and treatments
Puriﬁcation of Tx3-1 from the venom of the spider
Phoneutria nigriventer was performed following the
method of Cordeiro and coworkers (1993). Ab25-35, Ab35-25
and 4-aminopyridine (4-AP), were purchased from Sigma
(St. Louis, MO, USA). The Tx3-1 and 4-AP dose were based
on electrophysiological experiments that evaluated the
effect of both compounds on IA currents (Kushmerick et al.,
1999). Ab aggregationwas performed according to Maurice
et al. (1996), wherein 3 mM of either 25-35 or 35-25 (used
as control) sequence peptide were incubated at 37 C for 4
days, stored at 20 C and freshly diluted to the ﬁnal dose
(3 nmol/site; 1 mM) when used. In all behavioral experi-
ments, Ab25-35, Ab35-25, Tx3-1, 4-AP or vehicle, wereadministered by intracerebroventricular (i.c.v.) route, ac-
cording to Laursen and Belknap (1986). Brieﬂy, mice were
anesthetized with isoﬂuorane until full anesthesia was
achieved. The microinjections were performed using a
Hamilton 10 ml syringe connected to a specially made 28-
gauge stainless steel needle with 3 mm in length. The
needle was inserted directly through the skin and skull into
the lateral ventricle, targeted by visualizing an equilateral
triangle between the eyes and center of skull to locate
bregma, then inserting the needle 1 mm laterally to this
point. This avoids the use of unnecessary force since the
needle penetrates at the suture line of the skull plates.
Compounds were injected in a volume of 5 ml over a
5 s period, followed by a 10 s delay to allow diffusion and
prevent backﬂow. All injections were performed by an
experimenter well trained in this technique.
2.3. Novel object recognition task
Novel object recognition task was performed inwooden
chamber (30  30  30 cm) with black side and rear walls,
front wall made of transparent acrylic and the ﬂoor covered
with an ethyl vinyl acetate sheet. A light bulb, hanging
60 cm above the behavioral apparatus, provided constant
illumination of about 40 lux, and an air-conditioner pro-
vided constant background sound isolation. The objects
used were plastic mounting bricks, each of them with
different shapes and colors, but same size. Throughout the
experiments objects were used in a counterbalanced
manner and animals did not previously display preference
for any of the objects. Chambers and objects were thor-
oughly cleaned with 30% ethanol before each experiment.
Six days after Ab injection, novel object recognition task
was performed according to Wang and coworkers (Wang
et al., 2007), with minor modiﬁcations. The task consisted
of habituation, training and testing sessions, each of them
lasting 8 min. In the ﬁrst session, mice were habituated to
thebehavioral apparatus,withnoobjects, and then returned
to their home cages. Twenty-four hours later, training ses-
sion took place, when animals were exposed to two equal
objects (object A), and the exploration time was recorded
with two stopwatches. Exploration was recorded when the
animal touched or reached the object with the nose at a
distance of less than 2 cm. Climbing or sitting on the object
was not considered exploration. Immediately after training
the animals received the following drug treatments: Tx3-1,
4-AP or vehicle. The test session was carried out 2 (short-
term memory) or 24 (long-term memory) hours after
training, when mice were placed back in the behavioral
chamber and one of the familiar objects (i.e. object A) was
replaced by a novel object (i.e. object B). The time spent
exploring the familiar and the novel object was recorded.
The discrimination index was then calculated, taking into
account the difference of time spent exploring the new and
familiar objects ([(Tnovel – Tfamiliar)/(Tnovel þ Tfamiliar)]  100
(%)), and used as a memory parameter.
2.4. Assessment of adverse-effects
Aiming to identify any abnormal behavior that might
arise from central administration of Tx3-1 or 4-AP, we
Fig. 1. I.c.v. administration of Tx3-1 (10–300 pmol/site) enhances short-term
(A) and long-term (B) memory of naïve mice in the novel object recognition
task. I.c.v. administration of 4-AP (30–300 pmol/site) did no alter long-term
memory of naïve mice (C). Short-term memory was tested 2 h after training
and long-term memory 24 h after training. Tx3-1 and 4-AP were injected
immediately after training. Each column represents the mean of 6–14 ani-
mals, and vertical lines show the SEM. Statistical analysis was performed
using one-way analysis of variance (ANOVA) followed by SNK posttest;
*p < 0.05 denotes signiﬁcance level when compared to control.
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such as convulsions, coordination problems, muscular
weakness and paralysis (Dalmolin et al., 2011).
2.5. Statistical analysis
Statistical analysiswas performed using GraphPad Prism
Version 5.01. Values are given asmeanþ S.E.M. c2 test, one-
way, two-wayanalysis of variance (ANOVA)was performed,
followed by the Student-Newman-Keuls (SNK) post hoc test,
depending on the experiment. When possible, the effective
dose 50% (ED50) values were calculated by nonlinear
regression using a dose–response equation adjusted to
provide the best description of the values of the individual
experiments. Values of P< 0.05were considered signiﬁcant.
3. Results
3.1. Tx3-1 enhances memory of naïve mice: comparison with
the non-selective Kþ channel blocker 4-AP
In order to evaluate the effect of Tx3-1 on short-term
and long-term memory of naive mice, animals were
injected with Tx3-1 immediately after training session and
tested two or twenty-four hours afterward in the novel
object recognition task. We found no signiﬁcant difference
in the amount of time animals of all groups spent exploring
both the objects in the training session, indicating no
biased exploration of the objects (data not shown).
Administration of Tx3-1 (i.c.v., 300 pmol/site) in naive
mice signiﬁcantly increased the discrimination index for
the novel object when compared to vehicle group, both for
short-term memory (One-way ANOVA, F(4,27) ¼ 3.552,
p ¼ 0.0188 Fig. 1A) and long-term memory (One-way
ANOVA, F(4,45) ¼ 4.265, p ¼ 0.0052 Fig. 1B). Administration
of Tx3-1 (i.c.v., 10–300 pmol/site) induced no visible
adverse-effects in any dose tested (Table 1).
The effect of Tx3-1 on long-term memory was then
compared with the non-selective Kþ channel blocker 4-AP.
Administration of 4-AP (i.c.v., 30–300 pmol/site) did not
alter the discrimination index for the novel object task
when compared to vehicle group (One-way ANOVA,
F(3,21) ¼ 1.063, p ¼ 0.3858, Fig. 1C). More important,
administration of 4-AP induced toxic side effects, like
circling (30 pmol/site), freezing (100 pmol/site) and tonic–
clonic seizures (300 pmol/site), that started within 2–
3 min after i.c.v. injection (Table 1).
3.2. Tx3-1 administration reverses Ab25-35 – induced memory
impairment
We next tested the effect of Tx3-1 on long-term
memory of Ab25-35-treated animals. Injection of Ab25-35,
7 days prior to the novel object recognition task,
signiﬁcantly decreased the discrimination index of mice
when compared to Ab35-25 group (Fig. 2). Administration of
Tx3-1 (i.c.v., 10–100 pmol/site) signiﬁcantly restored the
discrimination index of Ab25-35-injected mice to the same
level of Ab35-25 group. Interestingly, Tx3-1 exhibited higher
potency to improve long-term memory of Ab25-35-treated
mice [(ED50 ¼ 2.0 (0.8–5.4 pmol/site), Fig. 2] than Ab35-25-treated mice [(ED50 ¼ 40.3 (10.3–158.4 pmol/site), Fig. 1B].
Statistical analysis (Two-way ANOVA) revealed a signiﬁcant
effect of Tx3-1 treatment on discrimination index of Ab25-
35-treated mice (F(3,43) ¼ 11.67, p ¼ 0.0001, Fig. 2).
Table 1
Adverse-effect assessment of Tx3-1 and 4-AP.
Group Dose
(pmol/site)
Adverse-effect assessment
Circling Freezing Tonic–clonic
seizures
Vehicle – 0/6 0/6 0/6
Tx3-1 10 0/6 0/6 0/6
30 0/6 0/6 0/6
100 0/6 0/6 0/6
300 0/5 0/5 0/5
4-AP 30 3/4* 0/4 0/4
100 0/4 4/4** 0/4
300 0/4 0/4 4/4**
c2 test, *P< 0.05; **P< 0.01, signiﬁcance level in comparison with control
(vehicle) group.
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The venom of the Brazilianwandering spider Phoneutria
nigriventer is a rich source of biologically active peptides,
including the toxin Tx3-1, a selective blocker of IA currents.
Here we showed that i.c.v. administration of Tx3-1
enhanced both short- and long-term memory of animals
tested in the novel object recognition task, without pro-
ducing any detectable adverse-effects. Moreover, Tx3-1
administration reversed the Ab25-35-induced memory
impairment, an established animal model of AD.
A-type Kþ currents (IA) play a key role in controlling
neuronal excitation (Hoffman et al., 1997), mainly through
regulation of EPSP and backpropagating action potential
amplitude (Chen et al., 2006; Ramakers and Storm, 2002).
Thus, modulation of IA currents might as well modulate
synaptic plasticity. Chen and coworkers (Chen et al., 2006)
have shown that hippocampal IA currents are crucial for
setting the threshold for LTP induction, since deletion of
Kv4.2, which eliminates IA, determines a lower threshold
for LTP induction in a theta burst pairing protocol.
Furthermore, upon LTP induction, in hippocampal orga-
notypic slice cultures, IA currents undergo a progressive
long-term decrease (Jung and Hoffman, 2009). Given that
LTP is considered the cellular mechanism for memory
acquisition, it is reasonable to think that modulation of IA
currents would impact memory storage capacity. Here,Fig. 2. I.c.v. administration of Tx3-1 restores long-term memory of Ab25-35-
injected mice in the novel object recognition task. Long-term memory was
tested 24 h after training. Tx3-1 (3–100 pmol/site) was injected immediately
after training. Each column represents the mean of 6–8 animals, and vertical
lines show the SEM. Statistical analysis was performed using two-way
analysis of variance (ANOVA); ***p < 0.001 denotes signiﬁcance level
when compared to Ab35-25-injected mice.using behavioral techniques, we showed in vivo evidence
that inhibition of IA currents enhance memory consolida-
tion, since i.c.v. administration of the IA blocker Tx3-1
improved short- and long-term memory of mice sub-
jected to the novel object recognition task.
We also examined the effect of the non-selective Kv
channel blocker 4-AP, applied at the same experimental
conditions that Tx3-1, on memory of mice. The i.c.v. injec-
tion of 4-AP had no effect on memory, but induced shaking,
circling and tonic–clonic seizures at the higher doses
tested. In fact, clinical trials have shown that although 4-AP
improves cognitive functions in AD patients, the incidence
of adverse-effects has hindered its clinical use (Davidson
et al., 1988; Wiseman and Jarvik, 1991). Interestingly, the
analysis of amino acid sequence of Tx3-1 shows no relation
to other Kþ channel blockers (Cordeiro et al., 1993). The lack
of homology with other known blockers of Kþ channels
could explain the selective pattern of toxin against IA cur-
rents, and thus a possible better therapeutic proﬁle when
compared to the non-selective Kv blocker 4-AP.
In vitro experiments shed light on the involvement of IA
currents in AD’s cognitive decline (Kerrigan et al., 2008;
Pan et al., 2004; Plant et al., 2006). The Ab peptide, which
accumulates in the brain of AD patients (Fraser et al., 1997;
Prince et al., 2009), alters synaptic plasticity (Holscher
et al., 2007; Cheng et al., 2009), and ion channel function,
such as potassium (Kþ) channels (Furukawa et al., 1996).
Moreover, current evidences suggest a role for Ab peptides
in IA Kþ currents regulation (Kerrigan et al., 2008; Pan et al.,
2004; Plant et al., 2006). Therefore, we evaluated whether
Tx3-1 alter Ab25-35-induced memory deﬁcits in mice.
Administration of Tx3-1, immediately after training ses-
sion, reversed the Ab25-35-induced memory impairment.
Interestingly, Tx3-1 proved to be more potent in Ab25-35-
treated mice when compared to the control group. One of
the causes of this better effect could be attributed to the
enhanced expression of cortical and hippocampal IA Kþ
channels induced by Ab25-35 (Pan et al., 2004). The higher
potency of Tx3-1 in AD-like conditions makes this toxin a
potential prototype for the emergence of more effective
therapies for AD-related cognitive decline. In line with this
view, Tx3-1 has been produced through bacterial expres-
sion system (Carneiro et al., 2002). This molecular biolog-
ical technique is useful to produce not only the
recombinant toxin but also to generate mutated versions of
the native peptide.
Here we reported the memory enhancing effect of
Tx3-1, a selective IA blocker, in physiological and AD-like
conditions in mice. Despite the data showed here, more
experiments, such as electrophysiological techniques, are
needed to better elucidate the effect of Tx3-1 on neuronal
mechanisms involved in memory storage.
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